Sanofi at ASHG 2026

Oct 20–24, 2026 Montréal, Canada ~7.5k attendees Website

Sanofi at ASHG 2026 in Montréal: 2 presentations (2 posters).

Organization	ASHG 2026 Attendance
Sanofi Cambridge, Massachusetts	1 Senior Scientist · 1 Senior Medical Director, Pompe & Fabry Disease
sanofi.com\|LinkedIn Public company~74,846 people Sanofi develops and delivers medicines and vaccines for patients worldwide. Its focus includes immunology, rare diseases, oncology, neurology, and vaccines. Won EU approval to extend its MenQuadfi meningitis vaccine to infants from six weeks old, broadening its pediatric vaccine market. › Won EU approval to extend its MenQuadfi meningitis vaccine to infants from six weeks old, broadening its pediatric vaccine market. 2026-08 · source Reorganized its executive committee into a more focused leadership team, a change that could shift strategic priorities. 2026-07 · source Won US approval for an on-body-injector, at-home version of its myeloma drug Sarclisa, improving patient convenience. 2026-07 · source Source: company newsroom Q2 2026 sales €11.6B, up 16% reported › 2026 guidance calls for about 10% sales growth at constant exchange rates. · 2026-07-30 “Net sales \| €11,597m \| +16.0% \| +17.8% ... sales are now expected to grow by around 10% at CER.” Source: results release Currently hiring: 803 open roles › Source: careers page	Poster Wed Oct 21 2:30 pm ★ Reviewers’ Choice Part of Artificial Intelligence and Machine Learning Poster Wednesday Session From human genetics evidence to therapeutic insights at scale: a calibrated language-model specialist for target discovery in immunology Exhibit & Poster Hall · Board 8068W Artificial intelligenceAutoimmune disorderGenome-wide association studyExpression quantitative trait loci Poster Fri Oct 23 2:30 pm Part of Statistical Genetics and Genetic Epidemiology Poster Friday Session Modeling prevalent cases of Pompe disease in the United States using newborn screening program data Exhibit & Poster Hall · Board 8430F Collaborators: Children's National Genetic epidemiologyLysosomal diseasesMathematical modelingMetabolic disorder

Organization

ASHG 2026 Attendance

Sanofi

Cambridge, Massachusetts

1 Senior Scientist · 1 Senior Medical Director, Pompe & Fabry Disease

sanofi.com|LinkedIn

Public company~74,846 people

Sanofi develops and delivers medicines and vaccines for patients worldwide. Its focus includes immunology, rare diseases, oncology, neurology, and vaccines.

Won EU approval to extend its MenQuadfi meningitis vaccine to infants from six weeks old, broadening its pediatric vaccine market.

›

Won EU approval to extend its MenQuadfi meningitis vaccine to infants from six weeks old, broadening its pediatric vaccine market.

2026-08 · source

Reorganized its executive committee into a more focused leadership team, a change that could shift strategic priorities.

2026-07 · source

Won US approval for an on-body-injector, at-home version of its myeloma drug Sarclisa, improving patient convenience.

2026-07 · source

Source: company newsroom

Q2 2026 sales €11.6B, up 16% reported

›

2026 guidance calls for about 10% sales growth at constant exchange rates. · 2026-07-30

“Net sales | €11,597m | +16.0% | +17.8% ... sales are now expected to grow by around 10% at CER.”

Source: results release

Currently hiring: 803 open roles

›

Source: careers page

Poster

Wed Oct 21
2:30 pm

★ Reviewers’ Choice

Part of Artificial Intelligence and Machine Learning Poster Wednesday Session

From human genetics evidence to therapeutic insights at scale: a calibrated language-model specialist for target discovery in immunology

Exhibit & Poster Hall · Board 8068W

Artificial intelligenceAutoimmune disorderGenome-wide association studyExpression quantitative trait loci

Poster

Fri Oct 23
2:30 pm

Part of Statistical Genetics and Genetic Epidemiology Poster Friday Session

Modeling prevalent cases of Pompe disease in the United States using newborn screening program data

Exhibit & Poster Hall · Board 8430F

Collaborators: Children's National

Genetic epidemiologyLysosomal diseasesMathematical modelingMetabolic disorder

Instantly find 20 buyers from Sanofi

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the American Society of Human Genetics. Submit a correction